|
SAR1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.71049907150245E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.76289996331758E-09 |
| Normal-vs-Stage2 |
4.45410000000646E-05 |
| Normal-vs-Stage3 |
3.76529996071184E-09 |
| Normal-vs-Stage4 |
2.36810016041034E-10 |
| Stage1-vs-Stage2 |
9.765200E-01 |
| Stage1-vs-Stage3 |
3.428200E-01 |
| Stage1-vs-Stage4 |
2.091900E-02 |
| Stage2-vs-Stage3 |
5.177200E-01 |
| Stage2-vs-Stage4 |
7.612400E-02 |
| Stage3-vs-Stage4 |
1.320990E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.40779626739618E-11 |
| Normal-vs-AfricanAmerican |
3.688100E-02 |
| Normal-vs-Asian |
4.73390004973595E-09 |
| Caucasian-vs-AfricanAmerican |
3.505800E-02 |
| Caucasian-vs-Asian |
2.659000E-01 |
| AfricanAmerican-vs-Asian |
2.369600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.9428999993626E-08 |
| Normal-vs-Female |
1.07529984916255E-10 |
| Male-vs-Female |
9.004200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.87240000463163E-08 |
| Normal-vs-Age(41-60Yrs) |
8.14940337434678E-11 |
| Normal-vs-Age(61-80Yrs) |
2.00570000052913E-07 |
| Normal-vs-Age(81-100Yrs) |
8.899600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.223800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.447200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.874400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.484800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.168400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.227000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.556140E-02 |
| Classical-VS-Follicular |
4.308000E-01 |
| Classical-VS-Other |
1.358220E-01 |
| Classical-VS-Normal |
2.203299764858E-10 |
| Tall-VS-Follicular |
6.403800E-03 |
| Tall-VS-Other |
7.880200E-01 |
| Tall-VS-Normal |
8.02110045050597E-10 |
| Follicular-VS-Other |
1.913030E-01 |
| Follicular-VS-Normal |
2.182400E-04 |
| Other-VS-Normal |
6.421400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.10689999575231E-08 |
| Normal-vs-N1 |
6.68243238521882E-13 |
| N0-vs-N1 |
2.816000E-04 |
|
|
